TY - GEN
T1 - Using CSF as an internal quality assurance tool in diffusion tensor imaging studies of brain tumor
AU - Wang, Jihong
AU - Shen, Yufei
AU - Degroot, John
AU - Shen, Yuzhong
AU - Li, Jiang
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009
Y1 - 2009
N2 - Purpose: Diffusion tensor imaging (DTI) is an inherently quantitative imaging technique that measures the diffusivities of water molecules in tissue. However, the accuracy of DTI measurements depends on many factors such S/N ratio and magnet field strength. Therefore, before quantitative assessment of tumor progression based on DTI metric changes can be made with confidence, one have to assess the accuracy or variance in the DTI metrics. This is especially important for multi-institutional clinical trials or for large institutions where patients may be imaged on multiple MR scanners at multiple times in follow up studies. In this presentation, we studied the feasibility of using CSF as an internal QC marker for data acquisition and processing qualities. Method: ADC and FA of CSF for brain tumor patients' DTI studies (total of 85 scans over three years) were analyzed. In addition, a phantom was used to check the inherent variations of the MR systems. Results: The results show that the coefficient of variations for ADC and FA are 8.4% and 13.2% in CSF among all patients. For all DTI scans done on 1.5 T scanners, they are 7.4% and 9.1%, while for 3T they are 9.8% and 18% respectively. Conclusion: CSF can be used as an internal QC measure of the DTI acquisition accuracy and consistency among longitude studies on patients, making it a potentially useful in multi-institutional trials.
AB - Purpose: Diffusion tensor imaging (DTI) is an inherently quantitative imaging technique that measures the diffusivities of water molecules in tissue. However, the accuracy of DTI measurements depends on many factors such S/N ratio and magnet field strength. Therefore, before quantitative assessment of tumor progression based on DTI metric changes can be made with confidence, one have to assess the accuracy or variance in the DTI metrics. This is especially important for multi-institutional clinical trials or for large institutions where patients may be imaged on multiple MR scanners at multiple times in follow up studies. In this presentation, we studied the feasibility of using CSF as an internal QC marker for data acquisition and processing qualities. Method: ADC and FA of CSF for brain tumor patients' DTI studies (total of 85 scans over three years) were analyzed. In addition, a phantom was used to check the inherent variations of the MR systems. Results: The results show that the coefficient of variations for ADC and FA are 8.4% and 13.2% in CSF among all patients. For all DTI scans done on 1.5 T scanners, they are 7.4% and 9.1%, while for 3T they are 9.8% and 18% respectively. Conclusion: CSF can be used as an internal QC measure of the DTI acquisition accuracy and consistency among longitude studies on patients, making it a potentially useful in multi-institutional trials.
UR - http://www.scopus.com/inward/record.url?scp=67249163992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67249163992&partnerID=8YFLogxK
U2 - 10.1117/12.812128
DO - 10.1117/12.812128
M3 - Conference contribution
AN - SCOPUS:67249163992
SN - 9780819475138
T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE
BT - Medical Imaging 2009
T2 - Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging
Y2 - 8 February 2009 through 10 February 2009
ER -